Jehaludi Ameena, Heist E Kevin, Giveans M Russell, Anand Rishi
Electrophysiology Deptartment, Holy Cross Hospital, Fort Lauderdale, FL, USA.
Electrophysiology Deptartment, Massachusetts General Hospital, Boston, MA, USA.
Indian Pacing Electrophysiol J. 2018 May-Jun;18(3):100-107. doi: 10.1016/j.ipej.2018.02.002. Epub 2018 Feb 21.
Although a rare complication of catheter based ablation for atrial fibrillation (AF), atrioesophageal fistula (AEF) is a serious and fatal event [1-5]. Most reports of AEF are single cases or small case series.
The purpose of this study was to perform a comprehensive literature search of all published atrioesophageal fistula following catheter ablation for AF in order to identify the mortality rates associated with therapeutic modalities and suggest the most definitive management in reducing mortality.
A comprehensive literature review of reported observational cases of atrioesophageal fistula post catheter based ablation for atrial fibrillation was performed.
Sixty-five cases of AEF post atrial fibrillation ablation were reviewed. The mean age was 55 years old. 73.8% (48/65) of the identified cases occurred in males (p < 0.001). Of the 65 cases, 13 underwent surgical radiofrequency ablation (RFA) and 52 underwent percutaneous RFA. Mortality resulted in 53.8% of those who underwent surgical RFA and in 55.8% of those who underwent percutaneous RFA (p = .888). The time range interval from procedure to onset of symptoms was 1-60 days. The most prevalent symptom, fever, occurred in 52 of the 65 cases, followed by neurological symptoms (n = 44). CT of the chest (n = 37), transthoracic echocardiogram (n = 21), and CT of the head (n = 18) were the preferred diagnostic modalities. Patients who underwent surgical correction with esophageal repair for treatment were more likely to survive, in comparison to patients who were treated with non-surgical interventions, such as antibiotic therapy, anticoagulation therapy or esophageal stenting. Of the total 34 patients who were treated surgically, 27 survived (79.4%). Of the total 31 patients who were treated non-surgically, only 2 survived (6.5%), reflecting significantly lower mortality with surgical versus non-surgical therapy (p < 0.001).
Atrioesophageal fistula is an uncommon but potentially fatal complication of atrial fibrillation ablation. Patients who underwent surgical repair were twelve times more likely to survive than those treated with stenting, antibiotic therapy or no intervention. Based on the observation that patients are 12 times more likely to survive an AEF with surgery than without, the authors believe that prompt surgical correction of AEF should be considered as standard of care when dealing with this dreaded complication.
尽管心房颤动(AF)导管消融术的一种罕见并发症,但心房食管瘘(AEF)是一种严重且致命的事件[1-5]。大多数关于AEF的报道为单例或小病例系列。
本研究的目的是对所有已发表的AF导管消融术后的心房食管瘘进行全面的文献检索,以确定与治疗方式相关的死亡率,并提出降低死亡率的最确切管理方法。
对已报道的基于导管消融治疗心房颤动后发生心房食管瘘的观察性病例进行全面的文献综述。
对65例房颤消融术后发生AEF的病例进行了回顾。平均年龄为55岁。73.8%(48/65)的确诊病例发生在男性(p<0.001)。在这65例病例中,13例接受了外科射频消融(RFA),52例接受了经皮RFA。接受外科RFA的患者死亡率为53.8%,接受经皮RFA的患者死亡率为55.8%(p=0.888)。从手术到症状出现的时间间隔为1-60天。最常见的症状是发热,65例中有52例出现,其次是神经症状(n=44)。胸部CT(n=37)、经胸超声心动图(n=21)和头部CT(n=18)是首选的诊断方式。与接受抗生素治疗、抗凝治疗或食管支架置入等非手术干预的患者相比,接受食管修复手术矫正治疗的患者更有可能存活。在总共34例接受手术治疗的患者中,27例存活(79.4%)。在总共31例接受非手术治疗的患者中,只有2例存活(6.5%),这表明手术治疗与非手术治疗相比死亡率显著降低(p<0.001)。
心房食管瘘是房颤消融术一种罕见但潜在致命的并发症。接受手术修复的患者存活的可能性是接受支架置入、抗生素治疗或不干预治疗患者的12倍。基于观察到接受手术治疗的AEF患者存活可能性比未接受手术治疗的患者高12倍,作者认为在处理这种可怕的并发症时,应将及时的手术矫正视为标准治疗方法。